These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38906216)

  • 1. Oral hormone replacement therapy and uterine volume in Korean adolescents with Turner syndrome: A retrospective case-control study.
    Choi E; Lee YJ; Kim HI; Kim H; Seo SK; Choi YS; Yun BH
    J Pediatr Adolesc Gynecol; 2024 Jun; ():. PubMed ID: 38906216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine Development During Induced Puberty in Girls with Turner Syndrome.
    Obara-Moszynska M; Dzialach L; Rabska-Pietrzak B; Niedziela M; Kapczuk K
    Front Endocrinol (Lausanne); 2021; 12():707031. PubMed ID: 34295308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pubertal development mode of Chinese girls with turner syndrome undergoing hormone replacement therapy.
    Guo S; Zhang J; Li Y; Ma H; Chen Q; Chen H; Du M
    BMC Endocr Disord; 2019 Jul; 19(1):72. PubMed ID: 31296213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHARACTERIZATION OF SPONTANEOUS AND INDUCED PUBERTY IN GIRLS WITH TURNER SYNDROME.
    Folsom LJ; Slaven JE; Nabhan ZM; Eugster EA
    Endocr Pract; 2017 Jul; 23(7):768-774. PubMed ID: 28332872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth.
    Lindsay Mart F; Gutmark-Little I; Streich-Tilles T; Trout AT; Khoury J; Bowers K; Casnellie L; Backeljauw P
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1040-e1047. PubMed ID: 37933636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Uterine Bleeding during Pubertal Induction with Transdermal Estrogen in Individuals with Turner Syndrome.
    Shim S; Streich-Tilles T; Gutmark-Little I; Yao M; Shafer J; Breech L; Casnellie L; Backeljauw P
    J Pediatr Adolesc Gynecol; 2023 Aug; 36(4):358-362. PubMed ID: 36934801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Dosage of 17ß-Estradiol on Uterine Growth in Turner Syndrome-A Randomized Controlled Clinical Pilot Trial.
    Cleemann L; Holm K; Fallentin E; Møller N; Kristensen B; Skouby SO; Leth-Esbensen P; Jeppesen EM; Jensen AK; Gravholt CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31613320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of the Rate of Increase of Estrogen Replacement Therapy on Bone Mineral Density Accrual in Young Patients with Turner Syndrome.
    Brander EPA; Keenahan LA; Sangi-Haghpeykar H; Graham M; Dietrich JE
    J Pediatr Adolesc Gynecol; 2023 Aug; 36(4):353-357. PubMed ID: 36934800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone therapy is associated with improved uterine dimensions in girls with Turner syndrome prior to oestrogen replacement.
    Mondal S; Gargari P; Nagendra L; Mandal S; Kumar RC; Shah P; Haldar M; Chowdhury S; Mukhopadhyay S
    Clin Endocrinol (Oxf); 2024 Jan; 100(1):66-75. PubMed ID: 37555570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone Replacement Therapy after Pubertal Induction in Adolescents and Young Adults with Turner Syndrome: A Survey Study.
    Dowlut-McElroy T; Kanakatti Shankar R
    Horm Res Paediatr; 2024; 97(1):62-69. PubMed ID: 37094554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-Onset Puberty Induction by Transdermal Estrogen in Turner Syndrome Girls-A Longitudinal Study.
    Gawlik AM; Hankus M; Szeliga K; Antosz A; Gawlik T; Soltysik K; Drosdzol-Cop A; Wilk K; Kudela G; Koszutski T; Malecka-Tendera E
    Front Endocrinol (Lausanne); 2018; 9():23. PubMed ID: 29472893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive role of pelvic magnetic resonance in the follow up of spontaneous or induced puberty in turner syndrome.
    Maggio MC; De Pietro A; Porcelli P; Serraino F; Angileri T; Di Peri A; Corsello G
    Ital J Pediatr; 2018 Feb; 44(1):24. PubMed ID: 29433553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
    Bannink EM; van Sassen C; van Buuren S; de Jong FH; Lequin M; Mulder PG; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):265-73. PubMed ID: 19200215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine development in Turner syndrome.
    Bakalov VK; Shawker T; Ceniceros I; Bondy CA
    J Pediatr; 2007 Nov; 151(5):528-31, 531.e1. PubMed ID: 17961700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor uterine development in Turner syndrome with oral oestrogen therapy.
    Paterson WF; Hollman AS; Donaldson MD
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):359-65. PubMed ID: 11940048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.
    Visser JA; Hokken-Koelega AC; Zandwijken GR; Limacher A; Ranke MB; Flück CE
    Hum Reprod; 2013 Jul; 28(7):1899-907. PubMed ID: 23539612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is There a Difference between Ultrasonographic (US) Uterine Changes of Oral Versus Transdermal (TD) 17β Estradiol (17β E2) in Girls with Turner Syndrome (TS)? Own Experience and Literature Review.
    Kraus J; Unanue N; Espinoza A; Iniguez G; Torres-Santiago L; Singh R; Mauras N; Mericq V
    Pediatr Endocrinol Rev; 2018 Sep; 16(1):178-185. PubMed ID: 30371036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Müllerian hormone levels in patients with turner syndrome: Relation to karyotype, spontaneous puberty, and replacement therapy.
    Hamza RT; Mira MF; Hamed AI; Ezzat T; Sallam MT
    Am J Med Genet A; 2018 Sep; 176(9):1929-1934. PubMed ID: 30088853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study.
    Nabhan ZM; Dimeglio LA; Qi R; Perkins SM; Eugster EA
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2009-14. PubMed ID: 19318455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Hormone Replacement Therapy on Bone Mineral Density in Korean Adults With Turner Syndrome.
    Kim S; Kim H; Lee I; Choi E; Baek J; Lee J; Kim HR; Yun BH; Choi YS; Seo SK
    J Korean Med Sci; 2024 Jan; 39(1):e9. PubMed ID: 38193328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.